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Mouse Strain Determines Cardiac Growth Potential
Carmen Kiper, Barry Grimes, Gary Van Zant, Jonathan Satin*
Department of Physiology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America
Abstract
Rationale: The extent of heart disease varies from person to person, suggesting that genetic background is
important in pathology. Genetic background is also important when selecting appropriate mouse models to study
heart disease. This study examines heart growth as a function of strain, specifically C57BL/6 and DBA/2 mouse
strains.
Objective: In this study, we test the hypothesis that two strains of mice, C57BL/6 and DBA/2, will produce varying
degrees of heart growth in both physiological and pathological settings.
Methods and Results: Differences in heart dimensions are detectable by echocardiography at 8 weeks of age.
Percentages of cardiac progenitor cells (c-kit+ cells) and mononucleated cells were found to be in a higher
percentage in DBA/2 mice, and more tri- and quad-nucleated cells were in C57BL/6 mice. Cardiomyocyte turnover
shows no significant changes in mitotic activity, however, there is more apoptotic activity in DBA/2 mice.
Cardiomyocyte cell size increased with age, but increased more in DBA/2 mice, although percentages of nucleated
cells remained the same in both strains. Two-week isoproterenol stimulation showed an increase in heart growth in
DBA/2 mice, both at cardiomyocyte and whole heart level. In isoproterenol-treated DBA/2 mice, there was also a
greater expression level of the hypertrophy marker, ANF, compared to C57BL/6 mice.
Conclusion: We conclude that the DBA/2 mouse strain has a more immature cardiac phenotype, which correlates to
a cardiac protective response to hypertrophy in both physiological and pathological stimulations.
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Introduction
The heart undergoes structural and morphological changes
during maturation and aging [1,2]. Such changes are driven by
the requirement of cardiac function to match demand as
individuals grow, and age. Natural genetic diversity imposes a
broad range of growth curves on human populations. By
contrast, inbred mouse strains used in research exhibit distinct
aging properties, and therefore provide a potential model
system to study growth. A major hindrance is the absence of
strain-specific information exploring strain-specific cardiac
phenotypes.
While it is unclear how the heart grows and adapts from
puberty until senescence, the old model that the heart is a
terminally-differentiated organ, whereby cardiomyocytes at
birth simply adapt to body growth and aging by changing size,
is overwhelmingly unsupported as the sole mechanism [3]. The
newer model of self-renewal posits that the heart contains a
continuum of pre-myocardial and mature-myocardial cell types
ranging from resident cardiac progenitor cells, to immature
cardiomyocytes, to mature cardiomyocytes containing
increasing nucleation in an age-dependent fashion [4,5]. This
paradigm of cardiac turnover has gained more credence in the
last couple of years, yet controversial issues persist,
particularly in humans where the extremely slow turnover of
cardiomyocytes creates experimental barriers [6,7]. Cardiac
progenitor cells are stem cells, differentiated to the point
whereby they are committed to a cardiac lineage that includes
further possible differentiation into smooth muscle cells,
endothelial cells, or cardiac myocytes [7–10]. Cardiac
progenitor cells are present in the heart in small numbers [11],
contain cardiac specific transcription factors [12], and can be
isolated by antibodies against c-kit [13,14]. Cardiac progenitor
cells differentiate into immature cardiomyocytes [10,15–18]
which are characterized as small, mononucleated myocytes
and exhibiting similar properties to embryonic-like
cardiomyocytes [4,5]. Immature cardiomyocytes can develop
into larger, multinucleated mature myocytes – about 80% of
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mouse heart cardiomyocytes are binucleated [4,5]. The
cardiomyocytes with three and four nuclei have the largest area
among cardiomyocytes and are considered the oldest
cardiomyocytes as these cells have the highest percentage of
apoptosis and the least chance of cellular division [4,5]. In this
study, we evaluated the response to aging and hypertrophy in
two mouse strains.
Genetic background influences physiology in many ways.
Inbred mouse strains have been used for years to study
specific diseases, but inbred strains often vary with their
responses to diseases [19]. Genetic background affects the
function of mouse hearts [20], and the response of the heart to
experimentally-induced pathological insult [21]. Understanding
the contribution of genetic background to physiology under
normal conditions is important for selecting appropriate strains
as models of disease, and has the potential to provide clues to
mechanisms of cardiac growth and repair.
This study is partially motivated by the finding that
hematopoietic stem cell (HSC) populations in DBA/2 compared
to C57BL6/J mice show distinct properties. HSCs are more
abundant in young adult DBA/2 compared to C57BL6/J mice
[22] and have a greater proliferative capacity in DBA/2 mice
[23]. HSCs from DBA/2 mice show more primitive
developmental characteristics than those from C57BL/6 [23].
The raises the provocative hypothesis that differential cardiac
progenitor cell population sizes exist in DBA/2 versus C57BL/6
hearts. Our data now support this contention, as DBA/2 hearts
contain more c-kit+ cells, and more mononucleated
cardiomyocytes in comparison to C57BL/6 hearts.
Methods
Animals:
All mice were purchased from Jackson Laboratories and
were housed in a pathogen-free facility and treated in
accordance with standard use protocols, animal welfare
regulations, and the NIH Guide for the Care and Use of
Laboratory Animals. The animal use protocol was approved by
the University of Kentucky Institutional Animal Care and Use
Committee.
Cardiomyocyte Isolation:
Euthanasia was performed by an injection of ketamine
+xylazine to anesthetize, followed by cervical dislocation and
heart excision. Single ventricular myocytes from female mice
were enzymatically isolated following a modified AfCS protocol
PP00000125 as previously described. Only rod-shaped,
quiescent cardiomyocytes with clear edges were selected for
analysis. There was no difference in the percentage of viable
rod-shaped cardiomyocytes isolated between the strains.
Pictures were taken using a 10x lens. Approximately 200
cardiomyocytes per heart were assessed. Cardiomyocyte area
was analyzed through ImageJ software.
Cardiac Progenitor Cell Isolation:
The isolation of the cardiac progenitor cells were based on a
protocol from Ronglih Liao’s laboratory [24,25]. Mice were
anesthetized (ketamine + xylazine) and cervically dislocated.
Hearts were excised and placed into cold PBS to rinse out the
extra blood. Hearts were individually placed in Petri dishes and
minced with 5ml of digestion buffer (2U dispase, 0.1%
collagenase, 2mM CaCl2, glucose, NaCl and NaHCO3-) using a
razor blade. Solution was mixed with cold HBSS solution buffer
(HBSS, 2% FBS (HI), 2mM HEPES), filtered first through a
70µm filter, and then a 40µm filter and stained with 1:100 with
antibodies: c-kit (eBioscience), CD45 and CD31 (BD). Solution
was filtered a third time with 35µm filter and sorted using a
FACS Aria cell sorter. FACS sorts that were outside of the 99%
confidence interval were considered outliers. Only cells that
were c-kit+/CD31-/CD45- were determined to be cardiac
progenitor cells.
Echocardiography:
Isoflurane combined with oxygen was used to sedate the
animals. Heart rate was monitored by ECG and was kept at a
constant rate among animals. Echocardiograms were done
with the VisualSonic 660 ultrasound machine with the
707-30mHz probe. Images were captured on the short axis
parasternal view and measurements were made in M-mode.
qRT-PCR:
Left ventricular free wall was cut from excised hearts and
flash frozen in dry ice and stored at -80oC until used. Lysates
were made using Trizol reagent. RNA was extracted (Ambion)
and cDNA was made (SuperScript II, Invitrogen). Probes were
bought commercially from BD. Samples (0.2ng of cDNA) were
run with the Taqman PCR Master Mix (Applied Biosystems).
Samples were run in triplicate on a 96-well optical plate with
the ABI 7700 Sequence Detection Software from Applied
Biosystems. All samples were normalized using GAPDH as an
internal control.
Hypertrophic hearts:
Osmotic mini pumps (Alzet, model 2002) were filled with
isoproterenol (30mg/kg/day) and were primed overnight.
Pumps were inserted subcutaneously into mice. Mice were
weighed and echocardiograms were conducted before pump
implantation, as well as at two weeks after pump implantation.
Mitotic Activity:
Mice were given BrdU (0.8mg/ml) in their drinking water for
10 days prior to the experiment, with the water changed daily.
At the endpoint, mice were euthanatized, the hearts were
perfused with cold PBS and then tissue was fixed with 4%
paraformaldehyde. The hearts were then excised and stored in
sucrose overnight. They were flash frozen in liquid nitrogen and
stored at -80° C until they were ready to be sectioned. Hearts
were sectioned at 4µm and then stained with the BrdU
visualization kit (Invitrogen). Pictures were taken with a 20x
lens on a phase contrast microscope and the BrdU+ nuclei
were counted as well as the total area of the section. Areas
containing large blood vessels were excluded from analysis.
Mouse intestine served as a positive control.
Strain-Specific Cardiomyocyte Populations
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Apoptotic Activity:
Hearts were prepared for sectioning as described in Mitotic
Activity (above). For a positive control, a mouse was injected
with doxorubicin IP (100µl, Bedford Laboratories) 48hrs before
hearts were taken. Sections were taken at 8µum and frozen
(20° C) before used. Sections were stained with the In-Situ Cell
Death Detection, POD kit (Roche) and then incubated with
fluorescein (PerkinElmer). Positively stained cells were viewed
at 20x on a phase-contrast microscope.
Statistical Analysis:
Experiments were determined significant by the student’s t-
test if p < 0.05, or by two-way ANOVA, p < 0.05. All data was
analyzed in the software program, PRISM, and are represented
as mean ± SEM.
Results
Comparison of in vivo dimensions and function
between strains
Baseline measurements of heart function and size were
conducted by echocardiography at 8 weeks of age. Diastolic
left ventricular chamber internal diameter was significantly
larger in the DBA/2 compared to C57BL/6. C57BL/6 and DBA/2
mice had indistinguishable fractional shortening and ejection
fraction. Body weight and heart weight were not different
between strains (Table 1). C57BL/6 and DBA/2 mice were
therefore considered functionally and structurally similar at 8
weeks of age.
Table 1. Basal characteristics of heart function in C57BL/6
and DBA/2 mice.
Parameters   
 DBA/2 C57BL/6
Bw (g) 20.54 ± 0.59 19.26 ± 0.30
IVS d (mm) 0.88 ± 0.06 0.85 ± 0.05
IVS s (mm) 1.09 ± 0.07 1.11 ± 0.06
LVID d (mm) 3.30 ± 0.10 3.05 ± 0.06*
LVID s (mm) 2.28 ± 0.10 2.07 ± 0.07
LVPW d (mm) 0.97 ± 0.05 1.03 ± 0.04
LVPW s (mm) 1.24 ± 0.06 1.29 ± 0.06
FS (%) 31.37 ± 1.95 31.76 ± 1.40
EF (%) 59.19 ± 2.6 60.61 ± 2.01
Hw (mg) 83.04 ± 5.88 78.22 ± 3.67
Hw:Bw (mg/g) 3.89 ± 0.25 4.01 ± .019
All data are represented as mean ± SEM
p < 0.05, student’s t-test
n = 27 (C57BL/6), 24 (DBA/2)
*. indicates significant between strains
Abbreviations: BW, body weight; IVS, intraventricular septum; LVID, left ventricular
internal diameter; LVPW, left ventricular posterior free wall; EF, ejection fraction;
FS, fractional shortening; HW, heart weight; HW:BW, heart weight : body weight; s,
systole; d, diastole
Cardiomyocyte size and degree of nucleation between
the two strains
A relatively new paradigm for heart growth homeostasis
posits a life-long turnover of cardiomyocytes [12], whereby
cardiac progenitor cells differentiate into small, beating
cardiomyocytes [8,10]. In turn, mononucleated cardiomyocytes
grow in size, become multi-nucleated and develop into fully
functioning mature myocytes. In this new paradigm, the fraction
of mononucleated myocytes can serve as a crucial indicator of
heart growth. We next wanted to assess the relative
proportions of mononucleated/binucleated cardiomyocytes in
our mouse strains.
Individual cardiomyocytes were isolated and size and
percentage of each number of nuclei were measured. The
fraction of mononucleated cardiomyocytes (relative to total
cardiomyocytes) is significantly greater in DBA/2 compared to
C57BL/6 mice. DBA/2 mice also had fewer tri- and quadri-
nucleated cells compared to C57BL/6 (Figure 1).
Cardiomyocyte size, for any given degree of nucleation, was
not significantly different between the two strains (data not
shown). Thus, based on an increased fraction of
mononucleated cardiomyocytes and a commensurate
decreased fraction of tri- and quadri-nucleated cardiomyocytes,
we conclude that the 8 week DBA/2 hearts have a relatively
immature phenotype compared to C57BL/6 heart.
Karyokinetic and apoptotic activity between the two
strains
In order to increase the number of nuclei within the cell, the
nucleus must replicate without cell division - termed
karyokinesis. We next measured the karyokinetic activity in
C57BL/6 and DBA/2 mice to determine if this could account for
the different percentages of nuclei. We focused on the apex of
the heart because of the reported concentration of cardiac
progenitor cells [10]. C57BL/6 mice had more mitotically active
cells, although the difference was not statistically significant
(Figure S1 A,C). Apoptosis was also measured in C57BL/6 and
DBA/2 hearts to further measure the turnover ability of the
cardiomyocytes. As cardiomyocytes get older, larger and
produce more nuclei, they will also increase their chance of
undergoing apoptosis [4,26]. TUNEL staining was used to stain
for apoptotic cells in histological sections of the apex of both
strains. C57BL/6 mice had a greater number of positively
stained cells compared to DBA/2, although the difference did
not reach statistical significance (Figure S1B,D).
Cardiomyocyte size with aging
Previous studies showed that the number of mononucleated
and multinucleated cardiomyocytes were dependent on age of
the animal, with younger animals containing more
mononucleated, or immature, cardiomyocytes [4,5]. We next
tested the hypothesis that there were differences in percentage
of nuclei with these two strains in both young and old animals.
Cardiomyocytes were isolated from mice at 3 weeks, 8 weeks,
1 year, and 2 years of age. Contrary to previous results [4,5],
the difference in the percentage of nucleated cardiomyocytes
across ages for within each strain was not strikingly different
(Figure S2 A–D). However, the cardiomyocyte cell area
Strain-Specific Cardiomyocyte Populations
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increased with age for all numbers of nuclei. The increase in
cell size was greatest in the DBA/2 mice (Figure 2). Overall
heart size was measured in 1 year and 2 year old mice and
compared to 8 week old mice (3 week mice were too small to
conduct echocardiograms). Heart size increased in both
strains, but increased in C57BL/6 mice the most (Figure 3A).
Heart function, as shown through ejection fraction and
fractional shortening, was preserved in DBA/2 mice with aging,
however C57BL/6 mice had a decrease in cardiac function,
resembling heart failure (Figure 3C,D). Individual
measurements of the left ventricular internal diameter show a
dilated ventricle with aging in C57BL/6 mice, again indicating a
failing heart, whereas DBA/2 mice showed no change in their
ventricular diameter with aging (Figure 3 E,F).
Cardiac progenitor cells in C57BL/6 and DBA/2 mice
DBA/2 mice had a greater number of primitive hematopoietic
stem cells at a young age than C57BL/6 mice [22]. This
Figure 1.  Comparison of cardiomyocyte composition show an immature phenotype for DBA/2 mice.  Hearts from seven
DBA and eight C57 mice were used for this analysis (200 cardiomyocytes per heart). A) Mononucleated cardiomyocyte fraction is
significantly higher in DBA than C57Bl/6 hearts; *p<0.05. B) Bi-nucleated cells have indistinguishable proportions in both C57BL/6
and DBA/2 mice. C) Tri-nucleated cells have a significantly higher percentage in C57BL/6 mice compared to DBA/2. D) Quadri-
nucleated cells have a significantly higher percentage in C57BL/6 mice compared to DBA/2.
doi: 10.1371/journal.pone.0070512.g001
Strain-Specific Cardiomyocyte Populations
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motivated the hypothesis that there would also be similar
strain-specific differences in the number of progenitor cells
found in the heart. Furthermore, more progenitor cells in the
heart would indicate a less differentiated, more immature heart.
To determine the number of progenitor cells, we assayed
hearts for the common cardiac progenitor marker, c-kit
[10,13,14,27]. Cells that were also positive for CD45
(hematopoietic) and CD31 (endothelial) were excluded [25,28].
DBA/2 mice had significantly greater percentages of progenitor
cells compared to C57BL/6 mice at 8 weeks of age (Figure 4).
C-kit+ cells were also isolated at 2 years of age in both strains.
By this age, C57BL/6 and DBA/2 mice had similar percentages
of c-kit+ cells (data not shown).
Isoproterenol stimulation shows greater response in
DBA/2 mice.
Isoproterenol is a well-established model for concentric
hypertrophy [29] and prolonged infusion eventually leads to
heart failure [30]. However, C57BL/6 mice are relatively non-
responsive compared to other strains for shorter isoproterenol
infusion periods [31,32]. Given that DBA/2 mice exhibit a
relatively immature heart compared to the C57BL/6, we tested
the hypothesis that DBA/2 mice had a greater heart growth
response range than C57BL/6 mice. In another cohort of
animals, heart size and function were measured via
echocardiography before and after continual isoproterenol
infusion to assess change in heart size and showed no
difference at baseline. DBA/2 mice showed a greater increase
in heart weight to body weight ratio compared to C57BL/6 mice
(Figure 5, Table 2). Individual cardiomyocytes were isolated,
Figure 2.  Average cardiomyocyte size increases with age for DBA/2 and C57BL/6 hearts; greater increase for DBA/
2.  Individual cardiomyocytes were isolated from hearts (n = 3, 7, 3 for 3-week, 8-week, and 1-year, respectively) from DBA/2, and
(n = 4, 8, 4) from C57BL/6 mice. Approximately 200 cardiomyocytes were counted from each heart. A) Mononucleated
cardiomyocytes are significantly larger in both strains with aging. B) Binucleated cardiomyocytes are significantly larger with aging
for both strains, and DBA/2 cardiomyocytes are also significantly larger than C57BL/6 by 1 year of age. C) Tri-nucleated
cardiomyocytes increase in size between 3 weeks and 8 weeks of age for both strains, and DBA/2 mice have significantly larger
cardiomyocytes compared to C57BL/6 by 8 weeks as well as at 1 year. D) Quadri-nucleated cardiomyocytes are significantly larger
from 3 weeks in the C57BL/6 mice at 8wks and at 1 year of age for both strains. #: indicates significant from 3 weeks of age, *:
indicates significant between strains; p < 0.05, 2-way ANOVA.
doi: 10.1371/journal.pone.0070512.g002
Strain-Specific Cardiomyocyte Populations
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and cell area measured. Similarly, isoproterenol-treated DBA/2
mice had an increase in cardiomyocyte cell area for
mononucleated and binucleated cardiomyocytes compared to
control (Figure 6). Relatively large tri- and quadri-nucleated
cardiomyocytes did not significantly increase in area.
Isoproterenol-treated C57BL/6 mice were not significantly
increased (Figure 6). Percentages of nuclei were analyzed and
were not significantly changed with isoproterenol-treatment in
either strain, similar to what has been shown in the literature
[33] (data not shown). Next, mRNA levels of atrial natriuretic
factor (ANF) were measured as an independent marker of
hypertrophic response to isoproterenol. Consistent with
differential growth measures, DBA/2 mice treated with
isoproterenol had a larger increase in ANF expression levels in
Figure 3.  Old C57BL/6 mice show a decrease in function with aging.  A) Heart weight increases in both strains with aging,
C57BL/6 mice increase the most. B) Heart weight : body weight tends to increase with aging, with C57BL/6 increasing the most,
although not significantly. Cardiac function as shown through ejection fraction (C) and fractional shortening (D) is decreased in
C57BL/6 mice with aging, whereas it is preserved in DBA/2 mice. Left ventricular internal diameter in diastole (E) and systole (F)
show a dilated chamber in C57BL/6 mice with aging and a preserved chamber diameter in DBA/2 mice with aging. *: indicates
significant between strains, #: indicates significant from 8 weeks of age; p < 0.05, 2-way ANOVA.
doi: 10.1371/journal.pone.0070512.g003
Strain-Specific Cardiomyocyte Populations
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comparison to the increase from isoproterenol-treated C57BL/6
mice (Figure 7A). ANF is also found in more embryonic tissues,
and its expression is recapitulated as a fetal response gene.
Since baseline levels of ANF were elevated in DBA/2 mice,
several other mRNA levels of fetal response genes were
measured to determine if DBA/2 mice displayed high levels of
other fetal genes. Similar to ANF, message levels of skeletal
actin were elevated in DBA/2 mice, whereas the adult form of
MHC (αMHC, also myh6) was not up-regulated in either mouse
strain (Figure 7B,C). Isoproterenol-induced hypertrophy can
result in an increase of extracellular matrix deposition [34].
Message levels of several types of collagen were measured
between the two strains. C57BL/6 showed more collagen with
isoproterenol compared to isoproterenol-treated DBA/2 mice
(Figure 7D,E).
Discussion
The major new finding in this study was that cardiac
hypertrophy, both age-related and pathological-stress-induced,
occurs in a strain-specific manner. This is the first study to
show that DBA/2 and C57BL/6 mice vary in the composition of
cardiomyocytes that are contained in the heart; DBA/2 mice
have more cardiac progenitor cells, more mononucleated
Figure 4.  DBA/2 mice have a greater percentage of c-kit+ cardiac progenitor cells.  C-kit+ cells were isolated through flow
cytometry. Only cells that were negative for CD31 and CD45 were considered cardiac progenitor cells. Left) Representative flow
cytometry showing c-kit+/CD45-/CD31- progenitor cells in C57BL/6 and DBA/2 mice (third quadrant, Q3). Right) DBA/2 mice have
an average of 4.2% of c-kit+ progenitor cells compared to C57BL/6 mice, which have an average of 2.5% progenitor cells; n = 7,8;
*p < 0.05, student’s t-test.
doi: 10.1371/journal.pone.0070512.g004
Strain-Specific Cardiomyocyte Populations
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cardiomyocytes and C57BL/6 mice have more tri- and quadri-
nucleated cardiomyocytes. DBA/2 mice also display fewer cells
undergoing cell cycling, manifested as fewer mitotic and
apoptotic cells. DBA/2 mice also have larger cardiomyocytes at
every age, albeit not significantly, and have a greater cardiac
hypertrophic response to isoproterenol treatment than C57BL/6
mice.
This study draws on the paradigm that the mature heart, at
any given age, contains an admixture of cardiomyocyte
precursors, and cardiomyocytes of varying ages [35]. A
relatively immature heart would then be expected to contain a
larger fraction of mononucleated cells, whereas maturing
hearts steadily increase multi-nucleation of cardiomyocytes
[4,5]. C-kit+ cells increase with aging and disease [17], and our
results now show an aging-dependent relative change in c-kit+
cells between C57Bl/6 and DBA strains. An interpretation of
this result suggests that in C57Bl/6 c-kit+ cell growth is more
plastic. In this context, our results demonstrating more c-kit+
cells and relatively more mononucleated cells in DBA/2 versus
C57BL/6 hearts suggests that the genetic background of
DBA/2 mice causes an immature heart phenotype at 8 weeks
of age.
Unexpectedly, our data show discordance between the
degree of multi-nucleation and cell size as a function of aging.
We observed an increase of cardiomyocyte size, but not an
increase in the fraction of multi-nucleated cardiomyocytes from
8 weeks to 2 years. In contrast, recent studies indicated that
there were differences in percentages of nuclei with age [4,5],
specifically that there were more mononucleated cells in
younger animals and more multinucleated cells in older
animals. Similar to the present study, human heart aging,
cardiac hypertrophy, and ischemic cardiomyopathy do not
affect the proportion of mono- and multinucleated
cardiomyocytes [33]. It is unclear why these studies show
discrepant results. The two studies showing age-dependent
increase of proportion of multi-nucleated cardiomyocytes were
done in cat and mouse (strain C57BL/6 [4,5],, whereas the
present study in C57BL/6 mice and the human study show no
age dependent change in proportions of multi-nucleation. Our
finding that both strains maintain the same percentage of cells
indicates that nucleation status is not necessarily part of normal
aging. The consistent finding that cardiomyocytes undergo
hypertrophy, for any given nucleation number, and as a
function of age, suggests that signaling pathways, distinct from
karyokinesis, influence normal aging-related heart growth.
Figure 5.  Response to isoproterenol treatment is greater in DBA/2 mice compared to C57BL/6.  A) Representative figures of
echocardiograms of the left ventricle before and after isoproterenol treatment.
B) Heart weight/Body weight ratio shows a greater increase in DBA/2 hearts in response to isoproterenol treatment compared to
C57BL/6 mice; n = 9, 10; p < 0.05, 2-way ANOVA.
doi: 10.1371/journal.pone.0070512.g005
Strain-Specific Cardiomyocyte Populations
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The finding that there is a static proportion of mono- to multi-
nucleated cardiomyocytes as a function of age does not
necessarily preclude an influence of karyokinesis for cardiac
growth homeostasis. Previous studies showed that myocyte
maturation is commensurate with increasing cell size as well as
increasing the number of nuclei [4,5]. Cardiomyocytes and
cardiac progenitor cells can also divide to replenish the reserve
pool from the cells that have differentiated [14,36]. Our
hypothesis was that the C57BL/6 hearts have more multi-
nucleated cells, and therefore would have an increase in
mitotic activity to create that many nuclei. We focused on the
apex of the heart for these measurements because this region
is enriched with CPCs [10], and thus allowed for greater
resolution in measurements. There was a trend for the
increased mean BrdU+ cells in C5BL/6 compared to DBA/2.
Moreover, it is interesting to note that the relationship between
mitotic activities in C57BL/6 versus DBA/2 mice is correlated in
the apoptotic activity between strains. These data suggest the
speculative hypothesis that C57BL/6 undergo more
Table 2. Heart function in C57BL/6 and DBA/2 mice
following two weeks of isoproterenol treatment.
Parameters Treatment   
 
C57BL/6
Control
C57BL/6
Isoproterenol
DBA/2
Control
DBA/2
Isoproterenol
Bw (g)
20.04 ±
0.33
21.75 ± 0.31
22.03 ±
0.63
21.93 ± 0.56
IVS d (mm)
0.7373 ±
0.038
0.9164 ± 0.066 #
0.8458 ±
0.043
0.9633 ± 0.04
IVS s (mm)
0.9609 ±
0.046
1.463 ± 0.091 #
1.078±
0.052
1.356 ± 0.056 #
LVID d (mm)
3.194 ±
0.079
2.997 ± 0.107
3.397 ±
0.115
3.541 ± 0.083*
LVID s (mm)
2.289 ±
0.061
1.573 ± 0.119 #
2.389 ±
0.073
2.343 ± 0.095*
LVPW d
(mm)
0.9727 ±
0.061
1.44 ± 0.11 #
1.001 ±
0.062
1.439 ± 0.077 #
LVPW s
(mm)
1.193 ±
0.065
1.79 ± 0.081 #
1.277 ±
0.062
1.743 ± 0.067* #
FS %
28.25 ±
1.22
47.27 ± 3.72 #
29.41 ±
1.26
33.99 ± 1.66* #
EF %
55.74 ±
1.80
78.21 ± 3.84 #
57.27 ±
1.78
63.5 ± 2.33*
Hw (mg)
71.88 ±
3.35
106 ± 6.86 #
90.35 ±
7.33
140.3 ± 7.87* #
Hw:Bw
(mg/g)
3.583 ±
0.15
4.924 ± 0.331 #
3.961 ±
0.30
6.435 ± 037* #
All data are expressed as mean ± SEM
p < 0.05, student’s t-test
n = 11 (C57BL/6), 12 (DBA/2)
# indicates significant from control
*. indicates significant between strains
Abbreviations: BW, body weight; IVS, intraventricular septum; LVID, left ventricular
internal diameter; LWPV, left ventricular posterior free wall; EF, ejection fraction;
FS, fractional shortening; Hw, heart weight; Hw:Bw, heart weight : body weight; s,
systole; d, diastole
cardiomyocyte turnover in the young adult heart. Turnover rate
has been shown to be changed under certain condition, such
as that associated with an increase in mitotic activity under
pathological conditions [37,38] or an increase in apoptotic
activity in aging [39,40]. A limitation of this study is that all
dividing cells and apoptotic cells were measured, and no
specific measurements between dividing cardiomyocytes
versus dividing CPCs versus dividing fibroblasts were made.
The finding that C57BL/6 have a greater fractional collagen
gene expression response to isoproterenol is consistent with
the notion that there might be differential fibroblast populations
across strains.
C-kit+ cell populations are strain specific, and the increased
number of c-kit+ cells in DBA/2 versus C57BL/6 correlates with
similar relationships in HSC pools [23]. The present study only
considers cells negative for CD31 and CD45 to preclude
endothelial and bone marrow cell contributions to our
measurements. Although we document relatively more c-kit+
cells in DBA/2 hearts, the contribution of cardiac resident c-kit+
cells is controversial. C-kit+ cells isolated from neonatal hearts
can differentiate into cardiomyocytes, but the cardiomyogenic
potential of adult c-kit+ cells is not apparent in cells from
normal adult heart [41]. Cardiac progenitor cells can contribute
to the growth potential of the heart through their differentiation
into cardiomyocytes in many different conditions, including the
addition of growth factors [18,42,43], as well as after an
infarction [44]. There has also been some evidence that
progenitor cells will proliferate under hypertrophic conditions
[17]. These findings in concert with our present study raise the
speculative, but exciting notion that for certain pathologies, and
in certain genetic backgrounds, the possibility exists for
variable degrees of intrinsic cardiac repair capabilities.
Understanding the signaling mechanisms behind progenitor
cell proliferation/differentiation will important to be able to utilize
progenitor cells as a therapy for myocardial infarctions and
other forms of heart disease.
There are many models of cardiac hypertrophy, but we
focused on isoproterenol-induced hypertrophy because of the
well-documented diminished response that C57BL/6 mice have
to isoproterenol stimulation [31]. Thus the differential growth
response between the two strains would be more discernable.
C57BL/6 mice have been shown to have a decreased
response to isoproterenol from their down-regulation of β-
adrenergic receptors [31,32], which might contribute to the
small increase in heart weight to body weight in the C57BL/6
mice compared to DBA/2. However, there is also the possibility
that the DBA/2 mice have a greater growth potential, as
evidenced by the large increase in heart weight to body weight
with isoproterenol. Also, the mono- and binucleated
cardiomyocytes in DBA/2 mice were responsive to
isoproterenol treatment, which comprise the majority of
cardiomyocytes within the DBA/2 heart. This illustrates the idea
that the relatively immature cardiomyocytes are the ones that
have the greater growth potential. Equally compelling are the
message levels of ANF in baseline, which is typically found in
the embryonic heart, and is also part of the recapitulated fetal
response genes seen in the hypertrophic and failing heart
[45,46]. This again supports the idea that the DBA/2 mouse
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strain has an immature cardiac phenotype. ANF is typically
released during high blood pressure, which increases diuresis
to reduce volume, thereby reducing blood pressure. High
baseline levels of ANF in DBA/2 mice could be due to higher
Figure 6.  Cardiomyocyte area is increased in isoproterenol-treated DBA/2 mice, but not in isoproterenol-treated C57BL/6
mice.  Individual cardiomyocytes were isolated from (n = 4) DBA/2 and (n = 5) C57BL/6 hearts. Approximately 200 cardiomyocytes
from each strain were counted. A) Mononucleated and (B) Binucleated cardiomyocytes show an increase in cell size with
isoproterenol treatment in DBA/2 mice. C) Tri-nucleated and (D) Quadri-nucleated cardiomyocytes show no significant difference in
size with isoproterenol treatment in either strain; *p< 0.05.
doi: 10.1371/journal.pone.0070512.g006
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resting blood pressure. However, other groups describe similar
blood pressure levels between DBA/2 and C57BL/6 mice [47],
so this is not a likely explanation. Similar to aging, we did not
see any alteration in the proportion of nucleated cells with
isoproterenol treatment, which again has been shown in human
studies [33], but contrary to those done in rats [48]. A possible
explanation for these discrepancies could be from the single
time-points in this study, giving a ‘snapshot’ view of the change
in proportions of nucleated cardiomyocytes. The present study
highlights that the mono- and bi-nucleated cardiomyocytes
appear to be the major contributory factor to the strain-specific
cardiac growth observed with isoproterenol treatment. The
greatest degree of growth occurs in the mononucleated
cardiomyocytes, which are significantly more abundant in the
DBA/2 mice compared to C57BL/6 mice.
We conclude that the DBA/2 and C57BL/6 mouse strains
may cycle their cardiomyocytes at different rates, but retain the
specific proportions of degree of nucleation of cardiomyocytes
during the period of growth from 3 weeks to 2 years. The
DBA/2 mouse contains more mononucleated myocytes, and
Figure 7.  mRNA levels of hypertrophic markers for DBA/2 have greater increase with isoproterenol compared to C57BL/
6.  A) ANF mRNA level shown in reference to GAPDH mRNA, B) BNP mRNA levels, C) skeletal actin mRNA levels, D) αMHC
mRNA levels, E) procollagen type3 a1, F) procollagen type 1a1; n = 3 (for control DBA/2) and 4 for all others; *p < 0.05.
doi: 10.1371/journal.pone.0070512.g007
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displays a greater range of responsiveness to hypertrophic
stimuli as well as preserved function with aging. In summary,
this work indicates that genetic background influences the
composition of cardiomyocytes within the heart, and that this
specific composition has the potential to limit (or aid) response
to pathological insults.
Supporting Information
Figure S1.  Mitotic and apoptotic activities tend to be
greater in C57BL/6 compared to DBA/2 mice.
A) Representative picture of mitotic activity manifested as BrdU
staining. Scale bar represents 100µm. B) Representative
picture of apoptotic activity assessed by TUNEL staining.
Below: Dapi staining of same slices. Scale bar = 100µm. C)
C57BL/6 mice have a higher although not significant number of
mitotically active cells in the heart compared to DBA/2 mice, n
= 4. D) C57BL/6 mice have a higher number of apoptotically
active cells in the heart compared to DBA/2 mice, however not
statistically significant, n = 5.
(TIF)
Figure S2.  Percentage of cardiomyocytes remains
constant with aging within each strain.
A) Mononucleated cardiomyocyte percentages remain higher
in DBA/2 mice from age 3wks to 2yrs. B) Binucleated
cardiomyocyte percentages are similar in both strains from age
3wks to 2yrs. And tri-nucleated C) and quadri-nucleated D)
cardiomyocytes percentages are higher in C57BL/6 mice from
age 3wks to 2yrs.
(TIF)
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